Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. - sprookjes - yvandenbroek - TriplyDB

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

http://www.wikidata.org/entity/Q34193846

about

The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.Pregnancy-specific glycoprotein 1 induces endothelial tubulogenesis through interaction with cell surface proteoglycans Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1 Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition Role of heparan sulfate in sexually transmitted infections HIV Associated Neurocognitive Disorders Heparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T Cells M- and T-tropic HIVs promote apoptosis in rat neurons Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.Functional role of syndecan-1 cytoplasmic V region in lamellipodial spreading, actin bundling, and cell migration Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection.Mouse models of neurological disorders: a view from the blood-brain barrier.Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.Human immunodeficiency virus-1 uses the mannose-6-phosphate receptor to cross the blood-brain barrier Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo.The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Novel mechanisms of central nervous system damage in HIV infection.Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.Heparan sulfate-dependent enhancement of henipavirus infection.Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update.Genetic variations in genes involved in heparan sulphate biosynthesis are associated with Plasmodium falciparum parasitaemia: a familial study in Burkina Faso.Transmembrane TNF-α Facilitates HIV-1 Infection of Podocytes Cultured from Children with HIV-Associated Nephropathy.When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?Glycoconjugate glycans as viral receptors.Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease Oral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cells gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue.Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificity.Brain Invasion by CD4(+) T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice.HIV-associated synaptic degeneration.A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.

P2860

Q24532969-C26F684F-F3B4-4F82-8684-152E238490FB Q24614349-D6D3DF4B-81EF-4BFA-8F4D-EF062A0D1C69 Q24670055-BB4E26E4-9715-480E-A179-96E0542033B7 Q27004059-3C51A2C3-E79C-4465-9430-00026F45458B Q27023959-8700E50E-FC6E-43C7-A052-250895EFC81F Q27023968-1E4C9D4D-36CD-4FC1-BAD6-56749E745850 Q27472216-ED4DACE9-3798-475F-886D-922DB5B1EF50 Q28572213-1A2A5E35-DABD-4CC5-AEE7-38F4732E15ED Q33395678-EB55C09C-7185-4F97-8D18-CA94B0331825 Q33532625-1FAFE6B2-87C9-49AA-97A9-57A3A17EAE7D Q33707527-728B952F-D6AA-4C06-8441-2E97BC3A8AC9 Q33897480-1E09D7BB-0C2C-4363-8837-0CC8D4079468 Q33911116-44C1B113-E875-4A5D-8CD5-0C7E775737FD Q33930493-338323AF-7D36-4D4C-AB55-98FD3704F430 Q33938994-32960FDA-45E4-4FF6-92DF-6482B08270B3 Q33951943-7E912E50-30EB-4C36-982B-940E04AB1C40 Q33962742-E366A532-F779-49E4-AD31-063C3EC891D4 Q34326270-64498CE4-3957-450E-9E2E-A2AF0FFADD59 Q34440312-18B84470-1EE2-439F-A04A-55C57D25CBE1 Q34634294-5DEFE571-0648-427D-B01F-CD7BF5219408 Q35125996-F889A28B-1767-4C50-8224-EB92EDD5B339 Q35149334-E13EC997-F87E-4178-90DC-9A3F9926A2D6 Q35177355-E6EEFE8D-1177-4A53-858A-C6CAF145B7DC Q35557261-E97277AD-ACA0-4426-8ECC-90CD5A8F8534 Q35634313-78DD5005-EA1F-40B2-9D37-45C40A939A53 Q35674470-8BD32DCA-3E59-4DA8-979B-CE157588F348 Q35677600-0EE52EBC-D556-4472-B267-0F44C0AE98B5 Q35708840-A05D9E77-B1F1-445B-9CD9-5F214167070C Q36000549-C1F2E1DD-EBAC-4190-9517-93A9844CDF52 Q36181815-7A077001-D514-4EAB-95B3-EA77BFA6E528 Q36188164-850EC27E-0DE3-4A8B-A1D7-1793F886505E Q36194868-7F7B6E00-B604-48FD-879C-E3D0D761B28A Q36373244-EC17C6B5-5CC8-4E40-A476-7FAEFCFD1177 Q36512300-FB710542-C514-4A5C-AA91-BC1533866798 Q36800904-6029A05F-57F8-489F-959B-CBCED7CD182A Q37333741-E3064FD8-DC21-4E36-9FFA-E3D8E1B8DD64 Q38300914-662C1011-B4CD-41CE-BB62-C859D5504A7A Q38912920-C075051D-D4BA-400A-8A23-CE64BBF8CA14 Q40066321-01B834CB-EC04-460D-811D-BAB92592E350 Q40374556-B14F671D-E9C0-4B78-8AEC-391540B286B0

P2860

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

http://www.wikidata.org/entity/Q34193846

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@ast

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@en

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@nl

type

label

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@ast

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@en

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@nl

prefLabel

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@ast

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@en

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@nl

P1433

Q34193846-CF14CA50-DBEF-417F-8468-A74457E8D23B

P1476

Q34193846-39290CAE-2538-4889-BC58-E22B0459E659

P2093

Q34193846-141162A7-F9B5-4881-96CD-A64136AAE757

Q34193846-56424D64-CEDF-430C-8EE2-4AD6282963B2

Q34193846-6C4D8339-B1CC-484D-8FDD-71070CF22B59

Q34193846-7048EE50-7856-4507-819A-69B1F8C66E8C

Q34193846-A207C3D8-CABC-46E9-AAEC-DB78BBDC03FD

Q34193846-A28539DC-F50B-4A6D-9D25-97DCEFA04228

Q34193846-A60FC05C-94AE-4BAC-9EA6-BF83244419DD

Q34193846-C4B4BB46-C4FE-42FB-BB12-555918725239

Q34193846-EF300423-2F1E-4F23-97E9-23B84DDBF575

Q34193846-F2029668-5070-4BB1-B011-A8BC68E8A1AC

P2860

Q34193846-0060CCC9-027A-4401-A33C-EE4975D0DADC

Q34193846-0290A67A-2402-49F2-9A10-F1F3ADB0C660

Q34193846-032ED1A4-1A29-4202-B5A5-CE5E0FA8D642

Q34193846-043E1199-AE41-4ECD-BC9F-6ABDF39090D5

Q34193846-096DFC49-AF96-4385-95E1-7A5A00986852

Q34193846-0CBAB72C-F420-47CC-A70D-B997813339F1

Q34193846-0CDA1DC5-6F6A-4FE8-BDB2-E373CC433FEA

Q34193846-0ECBECD0-31B3-4737-A59E-9B82927EC0B0

Q34193846-0FEF5117-AB54-42A9-A773-E96DEE3D760E

Q34193846-12411E6D-C88F-46DE-BE32-AD4C0D9CF1B8

P304

Q34193846-E822A597-DFBB-4405-9B69-55E3E16F00D7

P31

Q34193846-21C69FBF-96CC-4169-BD74-F179FEA6B65F

P356

Q34193846-857A64A8-FCAA-489D-A34C-C35B1238F131

P407

Q34193846-DADE0FB0-E0A0-44E8-A47F-E9BAFDFD0DEC

P433

Q34193846-25577F6C-290A-422A-9E1E-38449EB5EB3D

P478

Q34193846-6E58E40E-120B-4359-8D16-1C6081EDEBD3

P577

Q34193846-FD3DABE3-8ADD-42F7-9B39-E3B32B6AC84D

P5875

Q34193846-0B0BCCF5-1090-41C2-BAA5-3BA5231BE947

P698

Q34193846-3735ADE8-C6AE-48E3-A96F-DC5B7F6CB797

P932

Q34193846-7B602B60-B6A4-4CD1-9B2E-E97042B366EE

P356

JVI.78.12.6567-6584.2004

P1433

Journal of Virology

P1476

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

@en

P2093

Bernadette Van der Schueren

http://www.w3.org/2001/XMLSchema#string

Dana Gabuzda

http://www.w3.org/2001/XMLSchema#string

Didier Trono

http://www.w3.org/2001/XMLSchema#string

Guido David

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Esko

http://www.w3.org/2001/XMLSchema#string

Lianchun Wang

http://www.w3.org/2001/XMLSchema#string

Michael D Bobardt

http://www.w3.org/2001/XMLSchema#string

Milan Fiala

http://www.w3.org/2001/XMLSchema#string

Patrick Salmon

http://www.w3.org/2001/XMLSchema#string

Philippe A Gallay

http://www.w3.org/2001/XMLSchema#string

P2860

A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection

Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins

DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans

Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

Diversity of receptors binding HIV on dendritic cell subsets

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

P304

6567-6584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.78.12.6567-6584.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8542228

http://www.w3.org/2001/XMLSchema#string

P698

15163749

http://www.w3.org/2001/XMLSchema#string

P932

416544

http://www.w3.org/2001/XMLSchema#string